Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Meta-analysis results

From: The Role of Aerobic Training Variables Progression on Glycemic Control of Patients with Type 2 Diabetes: a Systematic Review with Meta-analysis

Analysis and sub-analysis Number of comparisons Meta-analysis Heterogeneity
Difference in means (%) Effect size 95% CI p value I 2 p value
Aerobic training 24 − 0.65 − 1.037 − 1.386; − 0.688 < 0.001 76% < 0.001
Non-progressive aerobic training 13 − 0.45 − 0.920 − 1.329; − 0.512 < 0.001 74% < 0.001
Presence of comorbidities 6 − 0.33 − 0.554 − 1.048; − 0.061 0.028 52% 0.065
Absence of comorbidities 3 − 0.79 − 1.358 − 2.556; − 0.159 0.026 86% < 0.001
Walking/running modalities 7 − 0.43 − 1.292 − 1.856; − 0.727 < 0.001 61% 0.018
Cycle ergometer modalities 2 − 0.156 − 0.643; 0.330 0.529 0% 0.753
Untrained participants 9 − 0.39 − 0.956 − 1.382; − 0.530 < 0.001 58% 0.013
Undefined participant’s training status 2 − 0.443 − 1.646; 0.759 0.470 84% 0.013
Progressive aerobic training 14 − 0.84 − 1.478 − 2.197; − 0.759 < 0.001 87% < 0.001
Presence of comorbidities 4 − 0.79 − 3.061 − 4.823; − 1.299 0.001 90% < 0.001
Absence of comorbidities 9 − 0.94 − 0.699 − 1.226; − 0.171 0.009 68% 0.001
Walking/running modalities 7 − 0.69 − 1.078 − 1.817; − 0.340 0.004 78% < 0.001
Mixed modalities 5 − 1.12 − 2.614 − 4.206; − 1.022 0.001 92% < 0.001
Untrained participants 11 − 0.99 − 1.808 − 2.688; − 0.927 < 0.001 89% < 0.001
Undefined participant’s training status 3 − 0.381 − 0.905; 0.143 0.154 0% 0.633
Progressive aerobic training (intensity) 6 − 0.57 − 1.625 − 2.903; − 0.348 0.013 92% < 0.001
Progressive aerobic training (duration) 4 − 0.93 − 2.264 − 3.603; − 0.926 < 0.001 84% < 0.001
Progressive aerobic training (intensity and duration) 6 − 1.27 − 1.422 − 2.544; − 0.300 0.013 89% < 0.001